Comment and reply on: The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis

Author： Joan L. Robinson   Krista L. Lanctôt  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.7, 2009-07, pp. : 1631-1633

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32––35 weeks: a Canadian-based analysis**

By Lanctôôt Krista L.   Masoud Shababa T.   Paes Bosco A.   Tarride Jean-Eric   Chiu Aaron   Hui Charles   Francis Philip L.   Oh Paul I.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3223-3237

Informa Healthcare

Access to resources Recommend Favorite

Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33–35 completed weeks’ gestational age in Canada*

By Paes Bosco   Steele Susan   Janes Marianne   Pinelli Janet  

Current Medical Research and Opinion, Vol. 25, Iss. 7, 2009-07 ,pp. : 1585-1591

Informa Healthcare

Access to resources Recommend Favorite

Comments and reply on The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries

By Soto Javier   Holmstrom Stefan   Buchholz Patricia   Walt John   Wickstrøm Jannie   Aagren Mark  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 1899-1902

Informa Healthcare

Access to resources Recommend Favorite

Comments and reply on: Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting

By Currie Craig J.   McEwan Phil   Poole Chris   Valentine William J.   Palmer Andrew J.   Lammert Morten   Nicklasson Lars   Foos Volker   Roze Stéphane  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 967-969

Informa Healthcare

Access to resources Recommend Favorite

A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home

By Novak Daniel   Lindholm Lars   Jonsson Monica   Karlsson Roger  

Scandinavian Journal of Public Health, Vol. 32, Iss. 5, 2004-10 ,pp. : 324-332

Informa Healthcare

Access to resources Recommend Favorite